Evidence map›Paper›PMID 33544212›Full record

ReviewCell and tissue research2021

Recent progress in induced pluripotent stem cell-derived 3D cultures for cardiac regeneration.

Kai-Li Wang, Qi Xue, Xun-Hong Xu, Fang Hu, Hong Shao

Abstract readReview
PubMed Publisher
In one paragraph

Review in Cell and tissue research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Hydrogels for Cardiac Tissue Regeneration: Current and Future Developments.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Recent Advances in Generation of In Vitro Cardiac Organoids.International journal of molecular sciences · 2023
    Review
  7. Review
  8. Cardiac tissue engineering: Multiple approaches and potential applications.Frontiers in bioengineering and biotechnology · 2022
    Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kai-Li WangDepartment of Cardiology, Chun'an First People's Hospital (Zhejiang Provincial People's Hospital Chun'an Branch), Zhejiang Province, Hangzhou, 311700, China.
Qi Xue *Department of Cardiology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.
Xun-Hong XuEmergency Department, Chun'an First People's Hospital (Zhejiang Provincial People's Hospital Chun'an Branch), Zhejiang Province, Hangzhou, 311700, China.
Fang HuMedical Department, Chun'an First People's Hospital (Zhejiang Provincial People's Hospital Chun'an Branch), Zhejiang Province, Hangzhou, 311700, China.
Hong ShaoDepartment of Cardiology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China. shaohong@hmc.edu.cn.ORCID http://orcid.org/0000-0002-0129-6945

Funding

Hangzhou Medical Technology Plan Project 0020190129Zhejiang Provincial Science and Technology Projects GF20H020041
6 · The paper itself

Abstract

Cardiovascular diseases are the leading cause of death in the world due to the high incidence of the diseases coupled with the limited therapeutic options. In recent years, advances in regenerative medicine have emerged as a promising treatment. Differentiation of induced pluripotent stem cells (iPSCs) into cardiac cells and emerging technologies allowing arrangement of cells into complex 3D tissue-like structures open new frontiers for transplantation and engraftment of these tissue patches onto the damaged heart. Despite the cells integrating and presenting initial neovascularization, the functional and electric properties of these patches are still not comparable with those of the host cardiac tissue. Future research optimizing maturation and integration of the iPSC-derived cardiomyocytes is paramount for cardiac cell therapy to attain clinical use. Herein, we will review the state of the art and the different approaches to constructing these 3D transplantable structures.

Indexed as

Cell DifferentiationGuided Tissue RegenerationHumansImaging, Three-DimensionalInduced Pluripotent Stem CellsMyocytes, CardiacTissue Engineering3D bioprintingCardiac regenerative medicineCell sheetsInduced pluripotent stem cellsiPSC-derived cardiomyocytesTissue engineering

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.